Loading...
Chemical structure of BMS 986120

GC18717

BMS 986120

Also known as 4-[4-[[6-methoxy-2-(2-methoxyimidazo[2,1-b][1,3,4]thiadiazol-6-yl)-1-benzofuran-4-yl]oxymethyl]-5-methyl-1,3-thiazol-2-yl]morpholine

BMS 986120 is a compound specifically targeting protease-activated receptor 4 (PAR4), which comparably inhibited platelet aggregation (PA) induced by activation peptides selective for PAR4 (PAR4-AP) in human and monkey blood in vitro (IC50 of 9·5±2·7 and 2·1±0·4nM, respectively)

ChemicalCAS1478712-37-6MW513.6FormulaC23H23N5O5S2
CAS number
1478712-37-6
Molecular weight
513.6
Formula
C23H23N5O5S2
Solubility
DMSO ： 3·33 mg/mL (6·48 mM; ultrasonic and warming and heat to 80°C)
InChIKey
MINMDCMSHDBHKG-UHFFFAOYSA-N
Catalogue number
GC18717
Brand
GLPBIO
Computed properties PubChem CID 72190270 · XLogP 4.2 · TPSA 153 Ų · H-bond donors 0
XLogP
4.2
TPSA
153 Ų
H-bond donors
0
H-bond acceptors
11
Rotatable bonds
7
Heavy atoms
35

SMILES CC1=C(N=C(S1)N2CCOCC2)COC3=CC(=CC4=C3C=C(O4)C5=CN6C(=N5)SC(=N6)OC)OC

Computed descriptors from PubChem (CID 72190270), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.